SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE APPROXIMATELY ONE BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.
Privately Held Companies
Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.
Publicly Traded Securities
Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.
02 Santé Ventures Strategy
We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.
03 Santé Capital Strategy
We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.
04 NewsroomSee All News
CNBC: Investors see growth opportunity in Femtech devoted to women’s…
March 21, 2022
Podcast: Military Physician Turns Early-Stage Venture Capitalist: A People’s Game,…
February 10, 2022
Molecular Templates’ Presentations at the 2022 ASCO Annual Meeting Demonstrate Advancement in PD-L1 and HER2 Programs
June 6, 2022
Iterion Therapeutics Announces Results from Phase 1 Dose Escalation Study of Tegavivint in Desmoid Tumors to be Presented at the 2022 ASCO Annual Meeting
June 3, 2022